Whorwood C B, Ueshiba H, del Blazo P
Division of Pediatric Endocrinology, New York Hospital-Cornell Medical Center, NY 10021.
J Steroid Biochem Mol Biol. 1992 Apr;42(2):211-21. doi: 10.1016/0960-0760(92)90030-m.
Recent reports have thrown doubt on the role of measurements of plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide (3 alpha-diolG) as a marker of peripheral androgen metabolism in women with polycystic ovarian syndrome and idiopathic hirsutism. It has been suggested that a plasma profile of C19 steroid glucuronides may be more informative. While preliminary data indicates that both 3 alpha-diolG and androsterone G (ADTG) may arise from adrenal steroid precursors, there have been no reports of C19 steroid glucuronides in women with non-classical, or late-onset congenital adrenal hyperplasia (NC-CAH), who constitute a significant proportion of the hirsute female population. We therefore measured plasma levels of 3 alpha-diolG, ADTG and dihydrotestosterone G (DHTG) before and following a standard Cortrosyn test in 15 symptomatic and 3 asymptomatic NC-CAH patients, 5 heterozygote carriers for 21-hydroxylase deficiency (NCHETS) and 18 normal women. The effects of chronic glucocorticoid (GCR) therapy (greater than 3 months) on the C19 steroid glucuronide profile in the symptomatic patients was also investigated. Baseline plasma levels of all 3 glucuronides were significantly (P less than 0.001) higher in symptomatic patients compared with either normals or NCHETS. However, the order of discrimination was ADTG greater than 3 alpha-diolG greater than DHTG. There were no significant differences between steroid glucuronide levels for NCHET and normal women and the C19 steroid glucuronide concentrations for the asymptomatic NC-CAH patients were greater than 2 SD above the normal means. Moderate clinical improvement was observed in all patients receiving oral GCR therapy and was accompanied by approx. 80% suppression of the plasma levels of all 3 C19 steroid glucuronides. This contrasts with a mean suppression of androstenedione of only 50%. However, plasma levels of the C19 steroid glucuronides were not significantly increased in response to a short ACTH stimulation test. This may be explained by the fact that the androgen glucuronides are thought to be peripherally formed metabolites derived from unconjugated glandular secreted androgen precursors and thus their synthesis at 60 min following adrenal stimulation may lag substantially behind that of their respective precursors. There were significant linear correlations between the levels of all 3 glucuronides, but neither correlated with Ferriman-Gallway scores, body mass index or 17-hydroxyprogesterone levels.(ABSTRACT TRUNCATED AT 400 WORDS)
近期报告对血浆5α-雄烷-3α,17β-二醇葡萄糖醛酸苷(3α-二醇G)作为多囊卵巢综合征和特发性多毛症女性外周雄激素代谢标志物的作用提出了质疑。有人提出,C19类固醇葡萄糖醛酸苷的血浆谱可能更具信息量。虽然初步数据表明3α-二醇G和雄酮G(ADTG)可能均来自肾上腺类固醇前体,但对于构成多毛女性人群很大比例的非经典或迟发性先天性肾上腺皮质增生(NC-CAH)女性,尚无C19类固醇葡萄糖醛酸苷的相关报道。因此,我们检测了15例有症状和3例无症状的NC-CAH患者、5例21-羟化酶缺乏杂合子携带者(NCHETS)和18例正常女性在标准促皮质素试验前后的血浆3α-二醇G、ADTG和双氢睾酮G(DHTG)水平。还研究了慢性糖皮质激素(GCR)治疗(大于3个月)对有症状患者C19类固醇葡萄糖醛酸苷谱的影响。与正常人和NCHETS相比,有症状患者所有3种葡萄糖醛酸苷的基线血浆水平均显著更高(P<0.001)。然而,鉴别顺序为ADTG>3α-二醇G>DHTG。NCHET和正常女性的类固醇葡萄糖醛酸苷水平之间以及无症状NC-CAH患者的C19类固醇葡萄糖醛酸苷浓度与正常均值相比均高于2个标准差,两者之间无显著差异。在所有接受口服GCR治疗的患者中均观察到中度临床改善,同时所有3种C19类固醇葡萄糖醛酸苷的血浆水平约被抑制80%。这与雄烯二酮平均仅被抑制50%形成对比。然而,短程促肾上腺皮质激素刺激试验后,C19类固醇葡萄糖醛酸苷的血浆水平并未显著升高。这可能是因为雄激素葡萄糖醛酸苷被认为是来自未结合的腺分泌雄激素前体的外周形成代谢产物,因此肾上腺刺激后60分钟时它们的合成可能大大落后于各自的前体。所有3种葡萄糖醛酸苷的水平之间存在显著的线性相关性,但均与费里曼-高尔韦评分、体重指数或17-羟孕酮水平无关。(摘要截取自400字)